Immunogold-silver staining-on-a-chip biosensor based on cross-flow chromatography.

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Nanotechnology

Background:

• Cardiac troponin I (cTnI) is a critical biomarker for diagnosing myocardial infarction.
• Conventional rapid test kits often lack sufficient sensitivity and efficiency for early detection.
• Immunogold-silver staining (IGSS) offers potential for signal amplification in biosensing applications.

Purpose of the Study:

• To develop and optimize an IGSS-based biosensor for enhanced detection of cardiac troponin I.
• To improve the signal-to-background ratio and overall detection capability compared to existing methods.
• To create a convenient and efficient IGSS-on-a-chip (IOC) device for practical application.

Main Methods:

• Cross-flow chromatography integrated with sequential IGSS (immunological reaction and silver intensification).
• Optimization of colloidal gold catalyst size (5-nm diameter favored) and blocking/washing steps to minimize background noise.
• Development of an IGSS-on-a-chip (IOC) device using plastic injection molding.

Main Results:

• The 5-nm gold nanoparticles provided the highest colorimetric signal.
• Optimized blocking and washing procedures effectively reduced background signals.
• The IOC biosensor demonstrated a 51-fold enhancement in detection capability compared to conventional rapid tests.
• Silver intensification yield was 19% higher with the IOC cross-flow method than traditional incubation.

Conclusions:

• The developed IGSS-on-a-chip (IOC) biosensor offers a highly sensitive and efficient platform for cardiac troponin I detection.
• This novel approach significantly enhances biomarker detection capabilities for potential clinical applications.
• The IOC method represents a substantial advancement over traditional rapid test kits for cardiovascular diagnostics.